ID

31490

Description

Study ID: 104619 Clinical Study ID: 63129 Study Title:A multinational, randomized, double-blind comparison of once daily subcutaneous fondaparinux sodium with placebo for the prevention of venous thromboembolic events in acutely ill medical patients (ARTEMIS). Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 3 Study Recruitment Status: Completed Generic Name: fondaparinux sodium Trade Name: Arixtra Study Indication: Thrombosis, Venous

Mots-clés

Versions (1)
  1. 28/08/2018 28/08/2018 -
Détendeur de droits

GlaxoSmithKline

Téléchargé le

28 août 2018

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY-NC 3.0
Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Retour au modèle Commentaires
Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Subcutaneous fondaparinux sodium for prevention of venous thromboembolic events; Study ID: 104619

Anglais

SAE Complementary Information Form

1 Formulaires  
Serious Adverse Event
Description

Serious Adverse Event

Alias
UMLS CUI-1
C1519255
Date of Birth
Description

Patient Date of Birth

Type de données

date

Alias
UMLS CUI [1]
C0421451
Age
Description

Age

Type de données

integer

Alias
UMLS CUI [1]
C0001779
Sex
Description

Gender

Type de données

text

Alias
UMLS CUI [1]
C0079399
Race
Description

Racial group

Type de données

text

Alias
UMLS CUI [1]
C0034510
Height
Description

Body Height

Type de données

integer

Unités de mesure
  • cm
Alias
UMLS CUI [1]
C0005890
cm
Weight
Description

Body Weight

Type de données

float

Unités de mesure
  • kg
Alias
UMLS CUI [1]
C0005910
kg
Detailed Description
Description

Serious Adverse Event; description

Type de données

text

Alias
UMLS CUI [1,1]
C1519255
UMLS CUI [1,2]
C0678257
Study Drug - Treatment Number
Description

Study Drug, Identifier

Type de données

integer

Alias
UMLS CUI [1,1]
C0304229
UMLS CUI [1,2]
C0600091
Date and of the FIRST administration of Study Drug
Description

Study Drug, Date and Time of First Study Treatment

Type de données

datetime

Alias
UMLS CUI [1,1]
C0304229
UMLS CUI [1,2]
C3899436
Date and of the LAST administration of Study Drug
Description

Study Drug, Date and Time of last Study Treatment

Type de données

datetime

Alias
UMLS CUI [1,1]
C0304229
UMLS CUI [1,2]
C3469597
UMLS CUI [1,3]
C1517741
UMLS CUI [1,4]
C0011008
UMLS CUI [1,5]
C0040223
Study drug ongoing (at the time of report)
Description

Experimental drug; Administration of medication; Continuous

Type de données

boolean

Alias
UMLS CUI [1,1]
C0304229
UMLS CUI [1,2]
C3469597
UMLS CUI [1,3]
C0549178
In case of Hospitalization: Date of admission
Description

serious adverse event; hospitalization; admission date

Type de données

date

Alias
UMLS CUI [1,1]
C1519255
UMLS CUI [1,2]
C1708385
UMLS CUI [1,3]
C1302393
Previous and concomitant Medications
Description

Serious Adverse Event, Pharmaceutical Preparations, Previous; Serious Adverse Event, Concomitant Agent

Type de données

boolean

Alias
UMLS CUI [1,1]
C1519255
UMLS CUI [1,2]
C0013227
UMLS CUI [1,3]
C0205156
UMLS CUI [2,1]
C1519255
UMLS CUI [2,2]
C2347852
Medical History and Concomitant Diseases
Description

Serious Adverse Event; Medical History; Concomitant Diseases

Type de données

boolean

Alias
UMLS CUI [1,1]
C1519255
UMLS CUI [1,2]
C0262926
UMLS CUI [1,3]
C0243087
SAE Follow-Up Information
Description

SAE Follow-Up Information

Alias
UMLS CUI-1
C1519255
UMLS CUI-2
C1522577
Adverse Event
Description

Serious Adverse Event

Type de données

text

Alias
UMLS CUI [1]
C1519255
Date of Evaluation
Description

Serious Adverse Event; Date of Evaluation

Type de données

date

Alias
UMLS CUI [1,1]
C1519255
UMLS CUI [1,2]
C0220825
UMLS CUI [1,3]
C0011008
Additional Information and Comments
Description

Serious Adverse Event; Additional Information, Comments

Type de données

text

Alias
UMLS CUI [1,1]
C1519255
UMLS CUI [1,2]
C1546922
UMLS CUI [1,3]
C0947611
Retour au début de la page

Similar models

SAE Complementary Information Form

1 Formulaires
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
Serious Adverse Event
C1519255 (UMLS CUI-1)
Patient Date of Birth
Item
Date of Birth
date
C0421451 (UMLS CUI [1])
Age
Item
Age
integer
C0001779 (UMLS CUI [1])
Item
Sex
text
C0079399 (UMLS CUI [1])
Gender
Code List
Sex
CL Item
Male (Male)
CL Item
Female (Female)
Item
Race
text
C0034510 (UMLS CUI [1])
Racial group
Code List
Race
CL Item
Caucasian (Caucasian)
CL Item
Black (Black)
CL Item
Asian, Oriental (Asian, Oriental)
CL Item
Other (Other)
Body Height
Item
Height
integer
C0005890 (UMLS CUI [1])
Body Weight
Item
Weight
float
C0005910 (UMLS CUI [1])
Serious Adverse Event; description
Item
Detailed Description
text
C1519255 (UMLS CUI [1,1])
C0678257 (UMLS CUI [1,2])
Study Drug, Identifier
Item
Study Drug - Treatment Number
integer
C0304229 (UMLS CUI [1,1])
C0600091 (UMLS CUI [1,2])
Study Drug, Date and Time of First Study Treatment
Item
Date and of the FIRST administration of Study Drug
datetime
C0304229 (UMLS CUI [1,1])
C3899436 (UMLS CUI [1,2])
Study Drug, Date and Time of last Study Treatment
Item
Date and of the LAST administration of Study Drug
datetime
C0304229 (UMLS CUI [1,1])
C3469597 (UMLS CUI [1,2])
C1517741 (UMLS CUI [1,3])
C0011008 (UMLS CUI [1,4])
C0040223 (UMLS CUI [1,5])
Experimental drug; Administration of medication; Continuous
Item
Study drug ongoing (at the time of report)
boolean
C0304229 (UMLS CUI [1,1])
C3469597 (UMLS CUI [1,2])
C0549178 (UMLS CUI [1,3])
serious adverse event; hospitalization; admission date
Item
In case of Hospitalization: Date of admission
date
C1519255 (UMLS CUI [1,1])
C1708385 (UMLS CUI [1,2])
C1302393 (UMLS CUI [1,3])
Serious Adverse Event, Pharmaceutical Preparations, Previous; Serious Adverse Event, Concomitant Agent
Item
Previous and concomitant Medications
boolean
C1519255 (UMLS CUI [1,1])
C0013227 (UMLS CUI [1,2])
C0205156 (UMLS CUI [1,3])
C1519255 (UMLS CUI [2,1])
C2347852 (UMLS CUI [2,2])
Serious Adverse Event; Medical History; Concomitant Diseases
Item
Medical History and Concomitant Diseases
boolean
C1519255 (UMLS CUI [1,1])
C0262926 (UMLS CUI [1,2])
C0243087 (UMLS CUI [1,3])
Item Group
SAE Follow-Up Information
C1519255 (UMLS CUI-1)
C1522577 (UMLS CUI-2)
Serious Adverse Event
Item
Adverse Event
text
C1519255 (UMLS CUI [1])
Serious Adverse Event; Date of Evaluation
Item
Date of Evaluation
date
C1519255 (UMLS CUI [1,1])
C0220825 (UMLS CUI [1,2])
C0011008 (UMLS CUI [1,3])
Serious Adverse Event; Additional Information, Comments
Item
Additional Information and Comments
text
C1519255 (UMLS CUI [1,1])
C1546922 (UMLS CUI [1,2])
C0947611 (UMLS CUI [1,3])
Retour au début de la page 

Contact

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Aide

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial